Go Back   Ultimate Nurse > Nursing Discussion Forums > Nursing News
Register

Notices

Reply
 
LinkBack Thread Tools Display Modes
Old 05-16-2008, 09:56 PM   #1
Administrator
 
cougarnurse's Avatar
 
Join Date: Oct 2006
Location: MidWest area
Posts: 4,726
Blog Entries: 14
Send a message via Yahoo to cougarnurse
Birth defects with Roche transplant drug

Thought this was interesting: FDA stresses birth defect risks with Roche drug - Yahoo! News
WASHINGTON - Health regulators warned again Friday that Roche and Novartis drugs prescribed to organ transplant patients can cause miscarriages and birth defects when used by pregnant women.
The Food and Drug Administration last October said it received reports of miscarriages and infants born with ear and mouth birth defects after their mothers took Roche's CellCept. At the time, FDA added its most serious warning to CellCept and a similar Novartis AG drug, Myfortic.
FDA spokesman Christopher Kelly said the agency has not received any new reports of pregnancy-related problems, but was concerned some doctors may not have seen the initial warning.
CellCept and Myfortic are used to suppress the body's immune system to avoid organ rejection in transplant patients.
In a notice posted online Friday, FDA said that before prescribing the drugs doctors should confirm their transplant patients are not pregnant, and are using effective contraception.
FDA said most of the reported problems came from mothers who were taking CellCept before their pregnancies were detected. Some of the patients were taking the drug for conditions it was not approved to treat — including rheumatoid arthritis and lupus.
A spokesman for Roche said it has not received any new reports of miscarriages or birth defects since updating the drug's labeling. The company previously reported 25 miscarriages among 77 women exposed to the drug between 1995 and 2007.
The agency said it will continue working with Roche and Novartis to reduce use of the drugs by pregnant women.
Friday's FDA warning was the second in less than two months for Roche's CellCept, which was the Swiss drugmaker's sixth best-selling drug last year with revenue of nearly $2 billion.
Last month FDA said it was investigating 16 patients who developed a rare neurological disease while taking the drug.
The disease, known as progressive multifocal leukoencephalopathy, attacks the brain and central nervous system and is usually fatal. Symptoms include vision problems, loss of coordination and memory loss. Patients who survive are often permanently disabled, according to the FDA.
Thoughts or comments?
cougarnurse is offline   Reply With Quote
Old 05-18-2008, 03:08 AM   #2
Member
 
Join Date: Apr 2008
Location: MN
Posts: 69
Re: Birth defects with Roche transplant drug

I just know that the transplant patients I've worked with over the years were all told not to get pregnant; that these drugs were very dangerous to the fetus, etc.

Cell Cept is a very good drug in suppressing the immune system; it only makes sense that if it messes with new cells it will cause havock.
JennyP is offline   Reply With Quote
Reply

Thread Tools
Display Modes



Similar Threads
Thread Thread Starter Forum Replies Last Post
Bed, birth & beyond nursebot Nursing News 0 10-02-2006 06:47 AM
Drug-free birth isn't heroism, it's humanism nursebot Nursing News 0 09-09-2006 05:59 AM
Roche says not embarrassed by cost of cancer drugs nursebot Nursing News 0 06-20-2006 11:59 AM
Nursing News - Care for Adults With Heart Defects Lacking in Europe nursebot Nursing News 0 04-28-2006 02:31 PM
birth control Anonymous Questions and Answers for NURSES 2 09-07-2004 01:39 AM



1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126